Sign In
Buy DBVT
$15.82
+0.0900 (+0.572%)
At Close: Jul 02, 2026
Why DBV Technologies Stock Is Jumping Today
12:33pm, Monday, 01'st Nov 2021
The company plans to announce new data for its experimental peanut allergy drug this week.
Down 36.6% in 4 Weeks, Here's Why You Should You Buy the Dip in DBV Technologies S.A. (DBVT)
11:29am, Monday, 01'st Nov 2021
DBV Technologies S.A. (DBVT) is technically in oversold territory now, so the heavy selling pressure might have exhausted.
DBV Technologies Shares Down On FDA Update For Its Peanut Allergy Program
08:00am, Wednesday, 27'th Oct 2021
DBV Technologies (NASDAQ: DBVT) has received communication from the FDA concerning the STAMP protocol submission for its modified Viaskin Peanut (mVP) development program. The agency would like to
DBV Technologies to Participate at Upcoming Investor Conferences
01:30am, Tuesday, 31'st Aug 2021
Montrouge, France, August 31, 2021
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
04:30pm, Friday, 06'th Aug 2021
AMF REGULATED INFORMATION Montrouge, France, August 6, 2021
DBV Technologies S.A. (DBVT) CEO Daniel Tassé on Q2 2021 Results - Earnings Call Transcript
05:59pm, Monday, 02'nd Aug 2021
DBV Technologies S.A. (DBVT) CEO Daniel Tassé on Q2 2021 Results - Earnings Call Transcript
DBV Technologies Reports Second Quarter 2021 Financial Results and Recent Business Developments
04:15pm, Monday, 02'nd Aug 2021
Montrouge, France, August 2, 2021
DBV Technologies to Report First Half 2021 Financial Results and Business Updates on August 2, 2021
04:30pm, Monday, 26'th Jul 2021
Montrouge, France, July 26, 2021
DBV Technologies to Present at Upcoming Investor Conferences
01:30am, Wednesday, 02'nd Jun 2021
Montrouge, France, June 2, 2021
Montrouge, France, May 19, 2021
DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021
05:00pm, Wednesday, 05'th May 2021
Montrouge, France, May 5, 2021
DBV Technologies Reports Q1 2021 Financial Results
01:30am, Monday, 03'rd May 2021
Montrouge, France, May 3, 2021
DBV Technologies to Participate in Upcoming Investor Conferences
01:30am, Thursday, 29'th Apr 2021
Montrouge, France, April 29, 2021
Ordinary and Extraordinary General Meeting of May 19, 2021 to be Held in Closed Virtual Session Due to COVID-19 Pandemic
01:30am, Wednesday, 28'th Apr 2021
Montrouge, France, April 28, 2021
DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors
04:30pm, Friday, 02'nd Apr 2021
Montrouge, France, April 2, 2021 DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors
